We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$103B
AUM Growth
-$8.16B
Cap. Flow
-$11.8B
Cap. Flow %
-11.46%
Top 10 Hldgs %
16.83%
Holding
4,113
New
322
Increased
874
Reduced
2,317
Closed
300

Sector Composition

Rank Sector Weight
1 Financials 11.17%
2 Technology 10.29%
3 Healthcare 9.29%
4 Consumer Staples 6.63%
5 Consumer Discretionary 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
3501
Ardelyx
ARDX
$1.25B
$112K ﹤0.01%
21,931
-3,785
-15% -$32.1K
CLD
3502
DELISTED
Cloud Peak Energy Inc
CLD
$111K ﹤0.01%
31,334
-17,649
-36% -$64.5K
AMRN
3503
Amarin Corp
AMRN
$290M
$110K ﹤0.01%
1,356
-175
-11% -$10.9K
NERV icon
3504
Minerva Neurosciences
NERV
$196M
$109K ﹤0.01%
1,550
-741
-32% -$48K
CVRR
3505
DELISTED
CVR Refining, LP
CVRR
$109K ﹤0.01%
11,496
+462
+4% +$4.44K
ZIXI
3506
DELISTED
Zix Corporation
ZIXI
$107K ﹤0.01%
18,802
+7,669
+69% +$43.1K
RXDX
3507
DELISTED
Ignyta, Inc.
RXDX
$107K ﹤0.01%
+10,365
New +$84.2K
YDKG
3508
Yueda Digital Holding
YDKG
$5.25M
$105K ﹤0.01%
25
-8
-24% -$36.3K
AMSC icon
3509
American Superconductor
AMSC
$1.48B
$103K ﹤0.01%
+22,332
New +$113K
CMRX
3510
DELISTED
Chimerix, Inc.
CMRX
$102K ﹤0.01%
18,768
-10,463
-36% -$55K
FLNT
3511
Fluent
FLNT
$99.9M
$99K ﹤0.01%
+3,274
New +$99.7K
ATRS
3512
DELISTED
Antares Pharma, Inc.
ATRS
$99K ﹤0.01%
30,444
-21,088
-41% -$59.8K
PETX
3513
DELISTED
Aratana Therapeutics, Inc.
PETX
$98K ﹤0.01%
13,528
+1,495
+12% +$9.19K
KPTI icon
3514
Karyopharm Therapeutics
KPTI
$161M
$97K ﹤0.01%
716
-306
-30% -$45.3K
DHT icon
3515
DHT Holdings
DHT
$2.95B
$95K ﹤0.01%
22,907
+9,869
+76% +$43K
JONE
3516
DELISTED
Jones Energy, Inc.
JONE
$95K ﹤0.01%
2,967
-5,914
-67% -$239K
JAKK icon
3517
Jakks Pacific
JAKK
$297M
$94K ﹤0.01%
+2,330
New +$106K
AXSM icon
3518
Axsome Therapeutics
AXSM
$12.3B
$93K ﹤0.01%
+16,953
New +$71K
NADL
3519
CALL
DELISTED
North Atlantic Drilling Ltd
NADL
$93K ﹤0.01%
+70,000
New +$147K
CORI
3520
DELISTED
Corium International, Inc.
CORI
$90K ﹤0.01%
+12,058
New +$71.7K
RELY
3521
DELISTED
Real Industry, Inc.
RELY
$89K ﹤0.01%
+30,886
New +$84.2K
HEPA
3522
DELISTED
Hepion Pharmaceuticals
HEPA
0
GSV
3523
DELISTED
Gold Standard Ventures Corp.
GSV
$86K ﹤0.01%
50,000
-180,000
-78% -$322K
ASC icon
3524
Ardmore Shipping
ASC
$669M
$85K ﹤0.01%
+10,440
New +$80.5K
DWSN icon
3525
Dawson Geophysical
DWSN
$149M
$85K ﹤0.01%
+22,793
New +$99.7K

Similar funds

Credit Suisse's Q2 2017 Portfolio in Review

As of Q2 2017, Credit Suisse held 4,113 positions worth $103B, down 7.4% from $111B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $11.8B in Q2 2017, closing 300 positions and reducing 2,317 holdings. Its most notable exit was Yahoo Inc, an estimated $316M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Credit Suisse opened a new position in Altaba Inc worth $587M.

  • Credit Suisse's largest Q2 2017 buy was Altaba Inc: 10,781,590 shares worth $587M.
  • Credit Suisse added most to UBS Group in Q2 2017, an estimated $204M increase.
  • Credit Suisse's biggest Q2 2017 reduction was US Bancorp, cutting an estimated $559M.
  • Credit Suisse fully exited Yahoo Inc in Q2 2017, selling an estimated $316M.
  • Credit Suisse's ten largest holdings make up 17% of its $103B portfolio in Q2 2017.
  • Credit Suisse opened 322 new positions and closed 300 in Q2 2017.
  • Credit Suisse's portfolio value fell 7.4% quarter-over-quarter to $103B.

Based on Credit Suisse's 13F filing for Q2 2017, filed 14 Aug 2017.